Wall Street falls as Trump imposes tariffs, but not as badly as feared The threat of a punishing trade war sent Wall Street ...

A global pharmaceutical company partnered with DelveInsight to create a robust and simplified solution enabling its top ...

Britain on Monday hit back at AstraZeneca over the collapse of a 450 million pound ($558.5 million) investment, saying the drugmaker had scaled back the research and development portion of its plans, ...

AstraZeneca scrapped plans for a £450 million UK vaccine plant after rejecting a £78 million government offer, citing ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The Financial Times leads on AstraZeneca's decision to scrap plans for a new vaccine manufacturing plant in Liverpool, ...

Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in ...

AstraZeneca is no longer pursuing plans for a 450 million pound ($558.32 million) vaccine manufacturing plant in Speke, ...

The pharmaceutical giant said it was no longer pursuing a £450 million investment in a vaccine manufacturing plant in ...

AstraZeneca is no longer pursuing plans for a 450 million pound ($558.32 million) vaccine manufacturing plant in Speke, Liverpool, a company spokesperson said on Friday. "Following discussions with ...

AstraZeneca will no longer invest 450 million pound ($558.3 million) at its vaccine manufacturing plant in northern England, the company said on Friday, citing a reduction in government support. The ...

Royal Society of Chemistry report says support for schools, universities and industry is needed for sector to thrive ...